Literature DB >> 15945074

Changes of mRNA expression of vascular endothelial growth factor, angiopoietins and their receptors during the periovulatory period in eCG/hCG-treated immature female rats.

Kanako Miyabayashi1, Takashi Shimizu, Chiaki Kawauchi, Hiroshi Sasada, Eimei Sato.   

Abstract

Angiogenic factors can induce the perifollicular capillary network in the theca interna that shows marked changes in and around the preovulatory luteinizing hormone (LH) surge. To get more information on their functional crosstalk, the aim of the present study was to investigate the manner of mRNA expression of vascular endothelial growth factors (VEGFs) 120, 164, angiopoietin (Ang)-1, Ang-2 and their specific receptors during the periovulatory phase. We used an established equine and human chorionic gonadotropins (eCG/hCG)-derived experimental model capable of stimulating naturally occurring follicular maturation, ovulation and corpus luteum (CL) formation. On day 28 postpartum, immature female rats were administrated s.c. with 10 IU of eCG to promote follicular development, followed 48 hr later by i.p. administration of 20 IU of hCG. Ovaries were dissected at 0, 6, 12, 18 and 24 hr after hCG treatment, and were obtained on day 30 in the untreated control. After induction of follicular growth by the eCG treatment, each mRNA expression of VEGF 120, VEGF 164, Neuropilin-1 and Flt-1 significantly increased. The peaks in mRNA expressions of VEGF120 and VEGF164 were both found at 18 hr after hCG treatment. Flk-1 mRNA expression maintained up to 6 hr after hCG treatment, and then decreased at 12, 18 and 24 hr after hCG treatment. Ang-2 mRNA expression increased in the ovaries at 6 and 12 hr after hCG treatment. Tie-2 mRNA expression decreased at 24 hr after the treatment of gonadotropins. Our findings suggest that ovarian vascular formation during the periovulatory period including preovulatory follicles, ovulation and CL formation may develop via crosstalk of the VEGF-Flt-1 and Ang-Tie2 systems.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15945074     DOI: 10.1002/jez.a.188

Source DB:  PubMed          Journal:  J Exp Zool A Comp Exp Biol        ISSN: 1548-8969


  7 in total

Review 1.  Ovulation: Parallels With Inflammatory Processes.

Authors:  Diane M Duffy; CheMyong Ko; Misung Jo; Mats Brannstrom; Thomas E Curry
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

2.  Placental Growth Factor Is Required for Ovulation, Luteinization, and Angiogenesis in Primate Ovulatory Follicles.

Authors:  Hannah R Bender; Heidi A Trau; Diane M Duffy
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

3.  Biomarkers of human oocyte developmental competence expressed in cumulus cells before ICSI: a preliminary study.

Authors:  Mourad Assidi; Markus Montag; Katrin Van der Ven; Marc-André Sirard
Journal:  J Assist Reprod Genet       Date:  2010-10-16       Impact factor: 3.412

Review 4.  The Inflammatory Cytokine Imbalance for Miscarriage, Pregnancy Loss and COVID-19 Pneumonia.

Authors:  Fortunato Vesce; Chiara Battisti; Michele Crudo
Journal:  Front Immunol       Date:  2022-03-11       Impact factor: 7.561

5.  Serum angiopoietin-2 and β-hCG as predictors of prolonged uterine bleeding after medical abortion in the first trimester.

Authors:  Maofeng Wang; Junqing Chen; Jun Ying; Jiong Yu; Bifei Huang; Zhaoxiang Ren; Xianyu Wang; Qiaoqiao Guo; Yunlai Wang; Liuyi Qiu; Hongsheng Yu; Rugen Wan
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

Review 6.  Molecular and cellular mechanisms for the regulation of ovarian follicular function in cows.

Authors:  Takashi Shimizu
Journal:  J Reprod Dev       Date:  2016-04-21       Impact factor: 2.214

7.  Equine Chorionic Gonadotropin Modulates the Expression of Genes Related to the Structure and Function of the Bovine Corpus Luteum.

Authors:  Liza Margareth Medeiros de Carvalho Sousa; Gabriela Pacheco Mendes; Danila Barreiro Campos; Pietro Sampaio Baruselli; Paula de Carvalho Papa
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.